Urges NJ DOH to increase public awareness on effects of xylazine.

This resolution urges the New Jersey Department of Health to increase public awareness about xylazine, a veterinary drug not approved for human use that is being used recreationally and linked to overdose deaths. It requests the Department to provide educational resources informing residents about xylazine's health risks - including its incompatibility with naloxone (used for opioid overdoses) and its frequent combination with fentanyl - which can cause severe complications like skin ulcers and dangerous respiratory depression. As a non-binding resolution, it does not create new law but calls on the Department to address this public health concern through targeted outreach. The resolution specifically highlights xylazine's role in rising overdose deaths in New Jersey and surrounding states.